Unique Plan Description: CT Surg Epoprostenol Nebulized-Continuous
Plan Selection Display: CT Surg Epoprostenol Nebulized-Continuous
PlanType: Medical                                 
Version: 1          
Begin Effective Date: 2021-07-01 05:52:00
End Effective Date: 2100-12-31 00:00:00
Last Updated Date: 2021-12-20 09:39:10
Available at all facilities: No

CT Surg Epoprostenol Nebulized-Continuous
Laboratory
	Blood Gases Arterial (ABG) - MH/WH/JE
		T;N, Stat, spec type = Blood
		Routine, Q8H, spec type = Blood
	Hemoglobin and Hematocrit
		T+1;0400, Routine, Q24H, spec type = Blood
Medications
		Epoprostenol Nebulized-Continuous GUIDELINES FOR USE- RESTRICTED TO Cardiothoracic Surgeons/Pulmonary Intensivists(NOTE)*
		<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><META content="text/html; charset=windows-1252" http-equiv=Content-Type><STYLE> BODY margin:0; P margin:0 </STYLE><META name=GENERATOR content="MSHTML 11.00.9600.20016(NOTE)*
	epoprostenol inhalation 1500mcg/50mL
		1,500 mcg, EVERY BAG, 20 ng/kg/min
		50 mL, Nebulization-Continuous
			Comment: ***Use IBW for dosing*** rounded to nearest 10kg.  INHALATION ONLY.  Contact provider for any dose adjustments.  Following discontinuation, monitor patient for rebound pulmonary hypertension for at least 60 minutes.
Patient Care
	Order Lab
		Enter order for ABGs as needed for increased oxygen needs

*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase